Per-Ola Johansson

406 total citations
7 papers, 280 citations indexed

About

Per-Ola Johansson is a scholar working on Infectious Diseases, Computational Theory and Mathematics and Hepatology. According to data from OpenAlex, Per-Ola Johansson has authored 7 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 3 papers in Computational Theory and Mathematics and 3 papers in Hepatology. Recurrent topics in Per-Ola Johansson's work include HIV/AIDS drug development and treatment (4 papers), Hepatitis C virus research (3 papers) and Computational Drug Discovery Methods (3 papers). Per-Ola Johansson is often cited by papers focused on HIV/AIDS drug development and treatment (4 papers), Hepatitis C virus research (3 papers) and Computational Drug Discovery Methods (3 papers). Per-Ola Johansson collaborates with scholars based in Sweden, Belgium and United States. Per-Ola Johansson's co-authors include Bertil Samuelsson, Åsa Rosenquist, Ingemar Kvarnström, Maxwell D. Cummings, Ronald Kalmeijer, Sandrine Vendeville, Guy De La Rosa, Pierre Raboisson, Magnus Nilsson and András Horváth and has published in prestigious journals such as Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Per-Ola Johansson

7 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Per-Ola Johansson Sweden 6 109 100 88 74 66 7 280
Naoki Ogura Japan 9 91 0.8× 187 1.9× 117 1.3× 29 0.4× 45 0.7× 19 374
John P. Maxwell United States 8 127 1.2× 79 0.8× 212 2.4× 27 0.4× 107 1.6× 23 409
Kenny Simmen Belgium 7 99 0.9× 121 1.2× 128 1.5× 31 0.4× 99 1.5× 8 327
John Pichardo United States 15 163 1.5× 153 1.5× 205 2.3× 48 0.6× 146 2.2× 30 458
Sandrine Vendeville France 11 184 1.7× 174 1.7× 135 1.5× 38 0.5× 144 2.2× 15 519
Norman M. Gray United Kingdom 8 230 2.1× 78 0.8× 67 0.8× 69 0.9× 219 3.3× 12 505
Emanuela Nizi Italy 13 238 2.2× 302 3.0× 49 0.6× 43 0.6× 159 2.4× 19 609
David C. McGowan Belgium 10 94 0.9× 121 1.2× 32 0.4× 24 0.3× 39 0.6× 11 276
Savina Malancona Italy 13 122 1.1× 215 2.1× 107 1.2× 21 0.3× 101 1.5× 21 413
Kevin X. Chen United States 14 211 1.9× 233 2.3× 210 2.4× 79 1.1× 163 2.5× 23 562

Countries citing papers authored by Per-Ola Johansson

Since Specialization
Citations

This map shows the geographic impact of Per-Ola Johansson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per-Ola Johansson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per-Ola Johansson more than expected).

Fields of papers citing papers by Per-Ola Johansson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per-Ola Johansson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per-Ola Johansson. The network helps show where Per-Ola Johansson may publish in the future.

Co-authorship network of co-authors of Per-Ola Johansson

This figure shows the co-authorship network connecting the top 25 collaborators of Per-Ola Johansson. A scholar is included among the top collaborators of Per-Ola Johansson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Per-Ola Johansson. Per-Ola Johansson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Rosenquist, Åsa, Bertil Samuelsson, Per-Ola Johansson, et al.. (2014). Discovery and Development of Simeprevir (TMC435), a HCV NS3/4A Protease Inhibitor. Journal of Medicinal Chemistry. 57(5). 1673–1693. 158 indexed citations
2.
Agback, Tatiana, Per-Ola Johansson, Jimmy Lindberg, et al.. (2012). Highly potent macrocyclic BACE-1 inhibitors incorporating a hydroxyethylamine core: Design, synthesis and X-ray crystal structures of enzyme inhibitor complexes. Bioorganic & Medicinal Chemistry. 20(14). 4377–4389. 23 indexed citations
3.
Kolm, Ann‐Sofie, Torben M. Andersen, Lars Calmfors, et al.. (2008). Svensk Finanspolitik: Finanspolitiska rådets rapport 2008. 3 indexed citations
4.
Bäck, Marcus, Per-Ola Johansson, Ingemar Kvarnström, et al.. (2007). Novel potent macrocyclic inhibitors of the hepatitis C virus NS3 protease: Use of cyclopentane and cyclopentene P2-motifs. Bioorganic & Medicinal Chemistry. 15(22). 7184–7202. 19 indexed citations
5.
Johansson, Per-Ola, Marcus Bäck, Ingemar Kvarnström, et al.. (2006). Potent inhibitors of the hepatitis C virus NS3 protease: Use of a novel P2 cyclopentane-derived template. Bioorganic & Medicinal Chemistry. 14(15). 5136–5151. 13 indexed citations
6.
Johansson, Per-Ola, Jimmy Lindberg, Michael J. Blackman, et al.. (2005). Design and Synthesis of Potent Inhibitors of Plasmepsin I and II:  X-ray Crystal Structure of Inhibitor in Complex with Plasmepsin II. Journal of Medicinal Chemistry. 48(13). 4400–4409. 28 indexed citations
7.
Johansson, Per-Ola, Yantao Chen, Michael J. Blackman, et al.. (2004). Design and Synthesis of Potent Inhibitors of the Malaria Aspartyl Proteases Plasmepsin I and II. Use of Solid-Phase Synthesis to Explore Novel Statine Motifs. Journal of Medicinal Chemistry. 47(13). 3353–3366. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026